|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pathological and physiological problems related to the in vitro culture of plants显示文摘 | DEBERGH P MAENE L | 1984 | Parasitica1984，40，： | 1 |
| 2 | Prefertilization bar- riers between different Bromeliaceae 显示文摘 | Vervaeke I Parton E Maene L | 2001 | Euphytica2001，118，： | 1 |
| 3 | Pollen tube growth and fertilization after different in vitro pollination techniques of Aechmea fasciata 显示文摘 | VERVAEKE I PARTON E MAENE L | 2002 | Euphytica2002，124，1： | 1 |
| 4 | Experimental studies of the fluid dynamics in the separation zone in dissolved air flotation显示文摘 | Maens L Lennart J Jan D | | 0，，10： | 1 |
| 5 | Experimental studies of the fluid dynamics in the separation zone in dissolved air flotation显示文摘 | MAENS L LENNART J JAN D | 2000 | Water Research2000，34，10： | 1 |
| 6 | A scheme for commercia propagation of ornamental plants by tissue cul*ure显示文摘 | Debergh P C Maene L J | 1981 | Scientia Horticulturae1981，14，4： | 1 |
| 7 | Pathological and physiological problems related to the in vitro culture of plants显示文摘 | Debergh P Maene L | 1984 | Parasitis1984，，43： | 1 |
| 8 | Off-pump coronary surgery: surgical strategy for the high-risk patient 显示文摘 | Van Belleghem Y Caes F Maene L | 2003 | Cardiovasc Surg2003，11，： | 1 |
| 9 | Off-pump coronary surgery: surgical strategy for the high-risk patient 显示文摘 | Van Belleghem Y Caes F Maene L | 2003 | Cardiovasc Surg2003，11，1： | 1 |
| 10 | Pathological and physiological problems related to the in vitro culture of plants显示文摘 | Debergh P Maene L | 1984 | Parasitis1984，43，： | 1 |
| 11 | Experimental studies of the fluid dynamics in the separation zone in dissolved air flo- tation 显示文摘 | Maens L Leinnart J Jan D | 2000 | Water Res2000，34，1： | 1 |
| 12 | Off-pump coronary surgery:surgical strategy for the high-risk patient 显示文摘 | Van Belleghem Y Caes F Maene L | 2003 | Cardiovasc Surg2003，11，1： | 1 |
| 13 | The effects of soil types and moisture levels on bacterial wilt disease of groundnut (Arachis hypogaea) 显示文摘 | Abdullah H Maene L M J Naib H | 1983 | Pertanika1983，6，： | 1 |
| 14 | Pancreatic head vs pancreatic body/tail cancer:Are they different?显示文摘BACKGROUND The impact of pancreatic tumor location on patient survival has been studied in large national data-based analyses which yielded controversial results.AIM To explore if pancreatic head cancer(PHC)and pancreatic body/tail cancer(PBTC)have different overall survival(OS),molecular signature and response to chemotherapy.METHODS We retrospectively queried patient records from July 2016 to June 2020 in our institution.Patient demographics,cancer stage on diagnosis,tumor location,somatic mutations,treatment,and survival are recorded and analyzed.A test is considered statistically significant if the P value was<0.05.RESULTS We reviewed 101 patients with complete records,among which 67(66.34%)were PHC and 34(33.66%)were PBTC.More PHC were diagnosed at younger age[61.49 vs 68.97,P=0.010],earlier stages(P=0.006)and underwent surgical resection(P=0.025).There were no significant differences among all mutations and pathways studied except for TP53 mutations(37.0%in PHC vs 70.0%in PBTC,P=0.03).OS was not statistically different between PHC and PBTC(P=0.636)in the overall population and in subgroups according to surgical resection status or stages.In terms of response to chemotherapy,chemotherapy regimens(FOLFIRINOX-based vs gemcitabine-based)didn’t impact disease free interval in those who had surgical resection in either PHC(P=0.546)or PBTC(P=0.654),or the duration of response to first line palliative treatment in those with advanced disease in PHC(P=0.915)or PBTC(P=0.524).CONCLUSION Even though PHC and PBTC have similar poor OS and response to chemotherapy,the different presentations and molecular profiles indicate they are different diseases.Utilization of molecular profiling to develop targeted therapy for individualization of treatment is needed. | Kai Sun Charisma Mylavarapu Aubrey Crenshaw Yuqi Zhang Enshuo Hsu Jiaqiong Xu Marilyn Niravath Stephen L Jones Adriana Ordonez Maen Abdelrahim | 2022 | World Journal of Gastrointestinal Oncology2022，14，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员